MX2023003033A - Compuestos y metodos para el tratamiento de infecciones por virus. - Google Patents

Compuestos y metodos para el tratamiento de infecciones por virus.

Info

Publication number
MX2023003033A
MX2023003033A MX2023003033A MX2023003033A MX2023003033A MX 2023003033 A MX2023003033 A MX 2023003033A MX 2023003033 A MX2023003033 A MX 2023003033A MX 2023003033 A MX2023003033 A MX 2023003033A MX 2023003033 A MX2023003033 A MX 2023003033A
Authority
MX
Mexico
Prior art keywords
compounds
virus infections
treating virus
treating
metabolite
Prior art date
Application number
MX2023003033A
Other languages
English (en)
Inventor
Marc Salome
Xavier Maniere
Original Assignee
Meletios Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meletios Therapeutics filed Critical Meletios Therapeutics
Publication of MX2023003033A publication Critical patent/MX2023003033A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a un compuesto de la siguiente fórmula (I): (ver Fórmula) (I) o una sal, éster, hidrato, derivado, profármaco o metabolito farmacéuticamente aceptable del mismo para usar en la prevención o el tratamiento de una infección por un virus en un individuo. (sin figura).
MX2023003033A 2020-09-17 2021-09-17 Compuestos y metodos para el tratamiento de infecciones por virus. MX2023003033A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306048 2020-09-17
EP21305200 2021-02-18
PCT/EP2021/075679 WO2022058533A1 (en) 2020-09-17 2021-09-17 Compounds for treating virus infections

Publications (1)

Publication Number Publication Date
MX2023003033A true MX2023003033A (es) 2023-06-09

Family

ID=77951710

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023003033A MX2023003033A (es) 2020-09-17 2021-09-17 Compuestos y metodos para el tratamiento de infecciones por virus.

Country Status (12)

Country Link
US (1) US20230364033A1 (es)
EP (1) EP4213822A1 (es)
JP (1) JP2023541960A (es)
KR (1) KR20230069132A (es)
CN (1) CN116437960A (es)
AU (1) AU2021342704A1 (es)
CA (1) CA3192518A1 (es)
CL (1) CL2023000731A1 (es)
CO (1) CO2023004589A2 (es)
IL (1) IL300858A (es)
MX (1) MX2023003033A (es)
WO (1) WO2022058533A1 (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1475314A (en) 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
FR2641276B1 (fr) 1988-12-30 1991-07-12 Sanofi Sa Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant
FR2663328B1 (fr) 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2694287B1 (fr) 1992-07-31 1994-09-16 Jouveinal Inst Rech Nouvelles cycloalkylalkylamines ligands aux récepteurs sigma, leur procédé de préparation et leur application en thérapeutique.
FR2713639B1 (fr) 1993-12-09 1996-08-30 Irj Nouveaux dérivés de 2-arylalkényl-azacycloalkanes ligands aux récepteurs sigma, leur procédé de préparation et leur application en thérapeutique.
FR2724656B1 (fr) 1994-09-15 1996-12-13 Adir Nouveaux derives du benzopyranne, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2725445B1 (fr) 1994-10-10 1996-10-31 Adir Nouveaux derives a structure 1-arylalkenyl 4-aryl alkyl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2751645B1 (fr) 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2021188564A1 (en) * 2020-03-16 2021-09-23 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound

Also Published As

Publication number Publication date
EP4213822A1 (en) 2023-07-26
AU2021342704A1 (en) 2023-05-04
KR20230069132A (ko) 2023-05-18
CN116437960A (zh) 2023-07-14
CO2023004589A2 (es) 2023-04-27
AU2021342704A9 (en) 2024-04-18
CA3192518A1 (en) 2022-03-24
JP2023541960A (ja) 2023-10-04
WO2022058533A1 (en) 2022-03-24
IL300858A (en) 2023-04-01
US20230364033A1 (en) 2023-11-16
CL2023000731A1 (es) 2023-11-24

Similar Documents

Publication Publication Date Title
PH12018500147A1 (en) Benzodiazepine derivatives as rsv inhibitors
MX2022015207A (es) Compuestos antivirales para tratar infecciones por coronavirus, picornavirus, y norovirus.
WO2017123884A8 (en) Heterocyclic compounds as rsv inhibitors
MX2022003984A (es) Compuestos heterociclicos antivirales.
TN2019000170A1 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
MX2010007375A (es) Nuevos derivados de lupano.
PH12020550107A1 (en) Chromane monobactam compounds for the treatment of bacterial infections
MX2009012418A (es) Derivados de quinazolin-oxima como inhibidores de hsp90.
PH12020552017A1 (en) 2,3-dihydro-1h-pyrrolizine-7-formamide derivative and application thereof
MX2018010878A (es) Compuestos de aril-monobactam biciclicos y metodos de uso de los mismos para el tratamiento de infecciones bacterianas.
MX2020011317A (es) Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih.
MX2021011606A (es) Compuestos dirigidos a prmt5.
PH12017502009A1 (en) Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
MX2021015056A (es) Compuesto de pirrolopirimidina y uso del mismo.
EA201991916A1 (ru) 1,4,6-ТРИЗАМЕЩЕННЫЕ-2-АЛКИЛ-1H-БЕНЗО[d]ИМИДАЗОЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ДИГИДРООРОТАТНЫХ ОКСИГЕНАЗНЫХ ИНГИБИТОРОВ
MX2021015854A (es) Composiciones y métodos para tratar trastornos del snc.
UY27577A1 (es) Inhibidores de la integrasa del vih
MX2020013297A (es) Compuestos para el tratamiento o la prevencion de enfermedades hepaticas.
MX2021012105A (es) Compuestos de pirrol.
MX2022012812A (es) Métodos para tratar el síndrome de liberación de citocinas.
MX2021011144A (es) Derivados de las benzodiazepinas como inhibidores del vsr.
MX2021001804A (es) Compuestos de urea y composiciones como inhibidores de atpasa de smarca2/brm.
WO2020251871A3 (en) Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
MX2023003033A (es) Compuestos y metodos para el tratamiento de infecciones por virus.
MX2023009445A (es) Compuestos de heterociclos tetraciclicos utiles como inhibidores de la integrasa del vih.